Orphan Drugs and Rare Diseases

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs.

Medical & Health Care

Submit new post
Thank you for posting.
Share it:
No content found.
There seems to have been an error, please try again.